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We found that reversible inactivation of mitochondrial complex I by S-nitroso-N-acetyl-D,L-penicillamine (SNAP) in isolated rat heart
mitochondria resulted in a three-fold increase in H2O2 production, when mitochondria were respiring on pyruvate and malate, (but not when
respiring on succinate or in the absence of added respiratory substrate). The inactivation of complex I and the increased H2O2 production were
present in mitochondria washed free of SNAP or NO, but were partially reversed by light or dithiothreitol, treatments known to reverse S-
nitrosation. Specific inhibition of complex I with rotenone increased H2O2 production to a similar extent as that caused by SNAP. The results
suggest that S-nitrosation of complex I can reversibly increase oxidant production by mitochondria, which is potentially important in cell
signalling and/or pathology.
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There is increasing interest in mitochondria as major sources
of cellular oxidants (reactive oxygen species, ROS, and reactive
nitrogen species, RNS), which may play physiological or
pathological roles. Physiologically, mitochondrial ROS and
RNS have been suggested to regulate mitochondrial functions
[1–3], and cell proliferation and differentiation [1,4]. Patholog-
ically, mitochondrial ROS and RNS have been implicated in
aging [5], diabetes [6], neurodegeneration [7,8], and cell death
[9–12]. Most mitochondrial ROS are thought to be derived from
superoxide produced from either complex I or III [13–17].
Subsequent dismutation of superoxide, particularly by mito-
chondrial superoxide dismutase, results in hydrogen peroxide
production. However, if or how mitochondrial ROS production
is regulated is poorly understood.
Nitric oxide (NO), peroxynitrite (ONOO−) and S-nitro-
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doi:10.1016/j.bbabio.2006.02.014different mechanisms (reviewed in [18]). However, part of this
inactivation can be reversed by reduced thiols or light,
treatments that are known to breakdown S-nitrosothiols
[3,19,20], suggesting that inactivation of the complex is due
to S-nitrosation of complex I protein. This is supported by the
fact that S-nitrosothiols can reversibly inactivate complex I even
in conditions where there is little or no free NO released [19],
suggesting that inactivation occurs by transnitrosation. Low
molecular weight S-nitrosothiols, such as S-nitrosoglutathione
(GSNO) or S-nitroso-N-acetyl-penicillamine (SNAP), can
directly transfer the NO+ group to reduced thiols (transnitrosa-
tion), including protein thiols, and this may be an important
means by which NO regulates proteins. Inactivation of complex
I by NO, ONOO− or SNO has been suggested to contribute to
the pathology of sepsis [21], Parkinson's disease [22], and heart
failure [23].
Because SNO reversibly inactivate complex I, and because
specific inhibitors of complex I can increase mitochondrial ROS
production, we were interested whether SNO inactivation of
complex I would result in increased mitochondrial ROS
production. It is not obvious how SNO inactivation of complex
I will effect ROS production as the inactivation may occur
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complex I. Thus, we tested the effect of SNO on ROS
production in isolated mitochondria.
2. Methods
Rat heart mitochondria were isolated using standard procedures of
homogenization and differential centrifugation [24]. Mitochondria (1 mg
protein/ml) were incubated in a stirred and thermostated (37 °C) 1 ml chamber
in the presence/absence of 1 mM SNAP (Alexis). The incubation buffer
contained 120 mM KCl, 10 mM HEPES, 2 mM MgCl2, 1 mM EGTA, pH 7.2
and either 1 mM pyruvate+1 mM malate or 5 mM succinate. After 30 min
incubation mitochondria were spun down in an Eppendorf microcentrifuge
(13,000 rpm, 5 min), washed 3 times with incubation buffer and resuspended in
1 ml of incubation buffer for Amplex Red assay of hydrogen peroxide
production or frozen for complex I assay. In some experiments, SNAP-treated
and washed mitochondria were suspended in 1 ml of ice-cold incubation buffer
and illuminated by a Fiber Optic Illuminator (WPI, 150 W halogen bulb) for
40 min or incubated in the presence of 1 mM DTT for 30 min. After treatment
with DTT, mitochondria were washed twice with incubation buffer to remove
residual DTT. In experiments where PTIO was used, 1 mM PTIO was added
together with 1 mM SNAP to the mitochondrial incubation mixture.
For determination of complex I activity, pellets were resuspended in 10 mM
KH2PO4 (pH 8) and freeze–thawed at least 3 times. The activity of complex I
was detected spectrophotometrically from the rate of decrease of NADH
absorbance at λ=340 nm, ε=6.81/mM/cm in the presence of added coenzyme
Q1 (Sigma). For determination of complex II–III activity, the rate of cytochrome
c reduction was measured at 550 nm (ε=19 mM−1 cm−1) in broken
mitochondria with succinate as described in [25]. Mitochondria (0.025 mg,
freeze–thawed 3 times) were incubated in 1 ml 25 mM KH2PO4, pH 7.2 for
10 min in the presence of 20 mM succinate, 2 μM rotenone and 2 mM NaN3.
The reaction was started by the addition of 10 μM cytochrome c.
Production of hydrogen peroxide by mitochondria was measured using
Amplex Red (Molecular Probes). Mitochondria were incubated in the
incubation buffer (see above) supplemented with 1 μM Amplex Red and 1 U/
ml horseradish peroxidase and the rate of hydrogen peroxide production was
determined by following the increase in fluorescence (excitation at 560 nm,
emission at 587 nm) at room temperature measured with a Shimadzu RF-1501
spectrofluorimeter. That the Amplex Red oxidation by mitochondria was due to
H2O2 was verified by adding catalase, which reduced this oxidation by more
than 80%. In the absence of mitochondria, there was no significant rate of
Amplex Red oxidation in the presence of pyruvate plus malate, succinate or
rotenone.
For measurement of reduced glutathione (GSH) levels, control or SNAP-
treated mitochondria (0.5 mg protein) were spun down (13,000 rpm, 5 min),
washed with incubation medium, suspended in 200 μl 50 mM Tris buffer (pH
7.4) and freezed/thawed 3 times. Then, monochlorobimane (Molecular Probes)
was added to the extract to a final concentration of 100 μM along with
glutathione S-transferase (1 U/ml, Sigma). After 60 min incubation at room
temperature the fluorescence (excitation at 380 nm and emission at 520 nm) was
measured in a BMG Fluostar Optima plate reader. 0–50 μMGSHwas used for a
calibration curve.
Mitochondrial respiration was measured using a Clark-type oxygen
electrode in the incubation buffer additionally supplemented with 5 mM
KH2PO4 and 1 mMADP. Respiratory control index measured as ratio of State 3/
State 2 respiratory rates with 1 mM pyruvate plus 1 mMmalate as substrates was
9.3±1.2.
Data are presented as means±standard error of at least 4 separate
experiments. Statistical analysis was performed using Student's t test.
Differences were regarded to be statistically significant at p<0.05.
3. Results and discussion
It has previously been shown that exposure of isolated
mitochondria to S-nitrosating NO donors (such as GSNO or
SNAP) results in rapid inactivation of complex I probably dueto its transnitrosation [19,26]. We tested whether SNAP-treated
mitochondria have higher rate of ROS production by treating
isolated rat heart mitochondria with 1 mM SNAP and then
assaying mitochondrial H2O2 production by Amplex Red assay.
Note that after treating mitochondria with SNAP for 30 min the
mitochondria were washed three times, so that there was no
SNAP present during the assay. As can be seen in Fig. 1A,
mitochondria oxidizing pyruvate plus malate produce low
levels of H2O2. After treatment of mitochondria with 1 mM
SNAP complex I activity was decreased by about 60% (Fig.
1B), and the rate of H2O2 production increased 2.8 fold (Fig.
1A). When SNAP-treated mitochondria were exposed to light, a
treatment known to destroy S-nitrosothiols, there was partial
recovery of complex I activity and return to low rates of
hydrogen peroxide production by mitochondria (Fig. 1),
suggesting that S-nitrosation of the complex may be responsible
for the ROS production. Similarly to SNAP, rotenone, a
selective inhibitor of complex I, caused a 3.9 fold increase in
ROS production by mitochondria (Figs. 1 and 2). Interestingly,
inhibition of complex I and stimulation of ROS production was
observed even when mitochondria were incubated with SNAP
in the presence of PTIO—a scavenger of NO that removes free
NO (Fig. 1). This suggests that inhibition was induced by a
transnitrosation reaction (i.e. transfer of an NO+ group from
SNAP to complex I) rather than being mediated by free NO
released from the NO donor.
Fig. 1C summarizes the data on complex I activity and H2O2
production obtained in mitochondria under these various
experimental conditions. There was a negative correlation
(r2 =0.85) between complex I activity and H2O2 generation: the
lower activity of complex I (reduced by treatment with SNAP,
rotenone, SNAP plus light) the higher the rate of H2O2
production. This suggests that inhibition of complex I activity
by S-nitrosation may be the cause for increased ROS production
by mitochondria.
In separate series of experiments, we tested whether
dithiothreitol (DTT) would reverse the SNAP-induced increase
in ROS production, as DTT is known to reverse S-nitrosation
and reverse the SNO-induced inhibition of complex I [19]. In
these experiments, SNAP-treatment decreased complex I
activity from 150±24 nmol/min/mg in control to 63±9 in
SNAP treated mitochondria (P<0.01), and subsequent 1 mM
DTT treatment increased the rate back to 108±16 (P<0.01). In
the same mitochondria, SNAP treatment increased H2O2
production from 30±3 pmol/min/mg in control to 159±17
after SNAP treatment (P<0.05), and subsequent exposure to
DTT decreased the rate back to 88±11 (P<0.05). Thus DTT
reversed both the SNAP-induced inhibition of complex I and
the increased ROS production, consistent with both being due to
S-nitrosation of complex I. The fact that DTT did not
completely reverse the SNAP-induced inhibition of complex I
and stimulation of ROS production suggests either that SNAP
also inhibits complex I by mechanisms other than S-nitrosation
or that DTT does not completely reverse the S-nitrosation.
Control, untreated mitochondria respiring on endogenous
substrates produced low levels of H2O2, and this rate was
stimulated 2.5 fold by the addition of pyruvate plus malate or 4
Fig. 1. Effect of SNAP on H2O2 production and complex I activity in isolated heart
mitochondria. Heart mitochondria were treated with 1 mM SNAP for 30 min in the
absence or presence of 1 mM PTIO (indicated as+PTIO) or with 2 μM rotenone for
about 5 min, then washed with buffer and used for measurement of H2O2 production
by Amplex Red assay (A) or complex I activity (B). Where indicated, SNAP-treated
mitochondria were exposed to light for 40 min (indicated as +light). C—correlation
between rate of H2O2 production and complex I activity in isolated heart
mitochondria. Each point represents mean of 2–3 repeats of measurements of
H2O2 production rate and complex I activity under particular conditions (untreated
(control), treated with SNAP, SNAP plus light, or rotenone) in 3–6 separate
mitochondrial preparations. Correlation coefficient (r2=0.85) was calculated using
SigmaPlot software. *Statistically significant difference from control (P<0.01),
#Statistically significant difference from SNAP-treated mitochondria (P<0.05).
Fig. 2. Effect of exogenous substrates on H2O2 production by isolated heart
mitochondria. During measurement of H2O2 production by Amplex Red
assay, control or SNAP-treated mitochondria were incubated in the absence
(−) or presence of added substrates: P+M − 1 mM pyruvate plus 1 mM
malate, P+M+Ro – 1 mM pyruvate plus 1 mM malate plus 2 μM rotenone,
S − 5 mM succinate, S+Ro − 5 mM succinate and 2 μM rotenone.
*Statistically significant difference (P<0.05) between the SNAP-treated and
control mitochondria in the presence of the same substrate combination.
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generation in the absence of exogenous substrates or in the
presence of succinate (±rotenone) was not changed by SNAP
treatment, but the rate in the presence of pyruvate plus malate
was substantially increased (Fig. 2). This indicates that the
H2O2 production of SNAP-treated mitochondria was related to
complex I function, rather than actions on other respiratory
chain complexes, decreased H2O2 removal or to any residual
SNAP associated with the mitochondria. We also tested whether
SNAP treatment had any effect on complex II–III activity, but
SNAP had no significant effect (rates in nmol/min/mg of 36±7
in control and 33±6 in SNAP-treated mitochondria).
Exposure of mitochondria to SNAP also induced depletion
of mitochondrial GSH (and possibly other reduced thiols):
after 20 min incubation with 1 mM SNAP, the content of
reduced thiols decreased from 8.3±1.8 nmol/mg protein in
control to 4.3± 1.1 nmol/mg protein in SNAP-treated
mitochondria. In principle, therefore, SNAP-induced ROS
production might result from glutathione depletion decreasing
H2O2 removal by mitochondrial glutathione peroxidase.
However, in practice, this level of glutathione depletion has
little effect on mitochondrial ROS production [27]. And the
findings that light reversed the SNAP induced H2O2
production and that SNAP had no effect on the rates of
H2O2 production in the presence of succinate or absence of
substrates are not consistent with the H2O2 production
resulting from glutathione depletion. The decrease in
mitochondrial glutathione might result from transnitrosation
or the increased mitochondrial ROS production.
Mitochondrial ROS production comes mainly from
complexes I and III [13–17]. Because SNAP inactivates
complex I and a specific complex I inhibitor, rotenone,
stimulates ROS to a similar extent as SNAP, it seems likely
that SNAP-induced ROS production comes from complex I.
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effect on ROS production when mitochondria were respiring
on succinate, indicating that SNAP had no relevant effect on
the rest of the respiratory chain. In mitochondria from some
tissues reversed electron transfer through complex I when
respiring on succinate results in very high rates of ROS
production [15], however in heart mitochondria we found
that preincubating the mitochondria in the absence of
substrate resulted in a relatively low rate of ROS production
in the presence of succinate (Fig. 2). The site(s) within
complex I from which ROS are derived is still controversial,
and has been attributed to either FMN, iron–sulphur centres
or bound quinones [14–17,28,29]. Our finding that SNAP
and rotenone stimulate complex I ROS production to a
similar extent (for similar complex I inhibition, Fig. 1C) is
consistent with both SNAP and rotenone inhibiting complex
I electron transfer downstream of a ROS generation site,
which due to inhibition of electron transfer becomes fully
reduced and therefore has increased ROS production.
NO itself has previously been found to acutely stimulate
ROS production by mitochondria, probably by inhibiting
complexes III or IV or reacting with ubiquinol, but this effect
is immediately reversed when the NO is removed [1,30–32]. S-
nitrosation of complex I may provide a longer lasting means of
modifying ROS production.
Superoxide, produced by mitochondria, may react rapidly
with NO to produce peroxynitrite, which may further inhibit
complex I, potentially resulting in a vicious circle contributing
to pathology [32]. Hydrogen peroxide, produced by mitochon-
dria, might also synergise with NO to induce cell death [30], or
alternatively may regulate protein kinase pathways [33,34],
transcription [35] and/or cell proliferation [4,35]. In conclusion,
our results suggest that S-nitrosothiol-induced nitrosation and
inhibition of complex I, causes a reversible increase in
mitochondrial ROS production. This might be important in
cellular signalling, aging or death.
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